Tag: ARK Genomic Revolution ETF

Family office deal-making rebounds in April with healthcare bets

Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

How CNBC Cures is bringing rare disease stories to a national audience

FDA vaccine head will step down in April after string of controversial decisions

FDA reversals leave investors worrying about the fates of other experimental drugs

FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease

Three decades into cystic fibrosis fight, Boomer Esiason and his son Gunnar are winning

FDA chief warns U.S. is losing ground to China in early drug development, calls for faster trial approvals

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal